JP2011519891A5 - - Google Patents

Download PDF

Info

Publication number
JP2011519891A5
JP2011519891A5 JP2011507892A JP2011507892A JP2011519891A5 JP 2011519891 A5 JP2011519891 A5 JP 2011519891A5 JP 2011507892 A JP2011507892 A JP 2011507892A JP 2011507892 A JP2011507892 A JP 2011507892A JP 2011519891 A5 JP2011519891 A5 JP 2011519891A5
Authority
JP
Japan
Prior art keywords
cyclobutyl
carbonyl
azetidin
oxy
diazepane
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011507892A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011519891A (ja
JP5780954B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2009/055418 external-priority patent/WO2009135842A1/en
Publication of JP2011519891A publication Critical patent/JP2011519891A/ja
Publication of JP2011519891A5 publication Critical patent/JP2011519891A5/ja
Application granted granted Critical
Publication of JP5780954B2 publication Critical patent/JP5780954B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011507892A 2008-05-08 2009-05-05 ヒスタミンh3受容体アンタゴニストとしてのアゼチジン類及びシクロブタン類 Expired - Fee Related JP5780954B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP08155915.5 2008-05-08
EP08155915 2008-05-08
US13946108P 2008-12-19 2008-12-19
US61/139,461 2008-12-19
PCT/EP2009/055418 WO2009135842A1 (en) 2008-05-08 2009-05-05 Azetidines and cyclobutanes as histamine h3 receptor antagonists

Publications (3)

Publication Number Publication Date
JP2011519891A JP2011519891A (ja) 2011-07-14
JP2011519891A5 true JP2011519891A5 (cg-RX-API-DMAC10.html) 2012-05-10
JP5780954B2 JP5780954B2 (ja) 2015-09-16

Family

ID=39720542

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011507892A Expired - Fee Related JP5780954B2 (ja) 2008-05-08 2009-05-05 ヒスタミンh3受容体アンタゴニストとしてのアゼチジン類及びシクロブタン類

Country Status (9)

Country Link
US (1) US8691804B2 (cg-RX-API-DMAC10.html)
EP (1) EP2300422B1 (cg-RX-API-DMAC10.html)
JP (1) JP5780954B2 (cg-RX-API-DMAC10.html)
CN (1) CN102015636B (cg-RX-API-DMAC10.html)
BR (1) BRPI0913057A2 (cg-RX-API-DMAC10.html)
CA (1) CA2721303C (cg-RX-API-DMAC10.html)
IL (1) IL208613A (cg-RX-API-DMAC10.html)
TW (1) TWI454468B (cg-RX-API-DMAC10.html)
WO (1) WO2009135842A1 (cg-RX-API-DMAC10.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0815591B8 (pt) 2007-08-22 2021-05-25 Astrazeneca Ab composto, composição farmacêutica, e, uso de um composto.
EP2391617B1 (en) 2009-02-02 2015-11-11 Evotec AG Azetidines as histamine h3 receptor antagonists
TW201039825A (en) 2009-02-20 2010-11-16 Astrazeneca Ab Cyclopropyl amide derivatives 983
CN102471235A (zh) * 2009-07-11 2012-05-23 拜耳医药股份有限公司 利用环烷基的放射性标记方法
AU2011218491C1 (en) 2010-02-18 2015-05-14 Astrazeneca Ab Processes for making cyclopropyl amide derivatives and intermediates associated therewith
EA201291384A1 (ru) * 2010-07-06 2013-07-30 Астразенека Аб Терапевтические агенты 976
EA023260B1 (ru) 2011-02-23 2016-05-31 Сувен Лайф Сайенсиз Лимитед Новые соединения в качестве лигандов гистаминовых h-рецепторов
UY34194A (es) 2011-07-15 2013-02-28 Astrazeneca Ab ?(3-(4-(espiroheterocíclico)metil)fenoxi)azetidin-1-il)(5-(fenil)-1,3,4-oxadiazol-2-il)metanona en el tratamiento de la obesidad?
WO2013151982A1 (en) 2012-04-03 2013-10-10 Arena Pharmaceuticals, Inc. Methods and compounds useful in treating pruritus, and methods for identifying such compounds
CA2878217C (en) 2012-08-23 2016-05-17 Suven Life Sciences Limited Acrylamide compounds as histamine h3 receptor ligands
EP2905276A4 (en) * 2012-09-05 2016-03-09 Zhejiang Hisun Pharm Co Ltd CRYSTALLINE FORMS OF AZETIDINONE COMPOUNDS AND MANUFACTURING METHOD
US20230130739A1 (en) 2020-03-26 2023-04-27 Cyclerion Therapeutics, Inc. DEUTERATED sGC STIMULATORS
CN112279809A (zh) * 2020-09-23 2021-01-29 山东省海洋化工科学研究院 一种2-氰基-4-氟吡啶的制备方法
CN115073276A (zh) * 2022-07-15 2022-09-20 济南大学 一种泊沙康唑主环杂质的制备及控制方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4956359A (en) 1985-02-28 1990-09-11 A. H. Robins Company, Inc. 3-aryloxy and 3-arylthioazetidinecarboxamides as anticonvulsants and antiepileptics
ZA861210B (en) 1985-02-28 1987-10-28 Robins Co Inc A H 3-aryloxyazetidinecarboxamides as anticonvulsants and antiepileptics
US6559140B2 (en) * 2000-03-09 2003-05-06 Abbott Laboratories Cyclic and bicyclic diamino histamine-3 receptor antagonists
WO2003004480A2 (en) * 2001-07-02 2003-01-16 Novo Nordisk A/S Substituted piperazine and diazepanes as histamine h3 receptor agonists
DE10150310A1 (de) 2001-10-11 2003-04-24 Bayer Ag Substituierte Piperazincyclohexancarbonsäureamide und ihre Verwendung
US20080045506A1 (en) 2004-10-15 2008-02-21 Glaxo Group Limited Pyrrolidine Derivatives as Histamine Receptors Ligands
ATE488496T1 (de) 2005-06-22 2010-12-15 Pfizer Prod Inc Histamin-3-rezeptorantagonisten
US8158673B2 (en) * 2005-10-27 2012-04-17 Pfizer Inc. Histamine-3 receptor antagonists
CA2634235A1 (en) * 2005-12-21 2007-07-05 Schering Corporation Combination of an h3 antagonist/inverse agonist and an appetite suppressant
BRPI0707916A2 (pt) 2006-01-13 2011-05-17 Hoffmann La Roche compostos, processo para a sua manufatura, composições farmacêuticas que os compreendem e uso destes compostos
US8106208B2 (en) * 2006-05-18 2012-01-31 Albireo Ab Benzamide compounds that act as NK receptor antagonists
CN105712977B (zh) * 2007-11-20 2021-06-29 詹森药业有限公司 作为组胺h3受体调节剂的环烷基氧基吡啶化合物和杂环烷基氧基吡啶化合物

Similar Documents

Publication Publication Date Title
JP4814783B2 (ja) ピラゾロピリジン誘導体
JP2014531465A5 (cg-RX-API-DMAC10.html)
HRP20180546T1 (hr) Supstituirani benzilindazoli za uporabu kao inhibitori bub1 kinaze za liječenje hiperproliferativnih bolesti
JP5166280B2 (ja) ピリミジン誘導体
HRP20120457T1 (hr) 4-(4-cijano-2-tioaril)dihidropirimidinoni i njihova uporaba
RU2481333C2 (ru) Производные 1,1,1-трифтор-2-гидрокси-3-фенилпропана
JP2012515761A5 (cg-RX-API-DMAC10.html)
JP2012525395A5 (cg-RX-API-DMAC10.html)
RU2018138050A (ru) Производные тиазолопиридина как агонисты gpr119
JP2014521711A5 (cg-RX-API-DMAC10.html)
JP2018534326A5 (cg-RX-API-DMAC10.html)
ES3034264T3 (en) 1h-pyrrolo[3,2-c]pyridine and 1h-pyrrolo[2,3-c]pyridine derivatives as tlr9 inhibitors for the treatment of fibrosis
RU2015144386A (ru) Циклоалкилнитрилпиразолопиридоны в качестве ингибиторов янус-киназы
JP2013519733A5 (cg-RX-API-DMAC10.html)
JP2016518344A5 (cg-RX-API-DMAC10.html)
RU2014139601A (ru) Ингибиторы серин/треониновых киназ
JP2016530299A5 (cg-RX-API-DMAC10.html)
JP2023538608A5 (cg-RX-API-DMAC10.html)
JP2018508553A5 (cg-RX-API-DMAC10.html)
JP2019511466A5 (cg-RX-API-DMAC10.html)
JP2006528147A5 (cg-RX-API-DMAC10.html)
US6897318B2 (en) Process for making substituted pyrazoles
JP2024534169A5 (cg-RX-API-DMAC10.html)
TW202543627A (zh) Stat6降解劑
EP4615824A1 (en) Substituted quinolone compounds useful as inhibitors of tlr9